Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice come back yesterday, looking for a much better pps this coming week.
Follow up news could send this one over $5 easily... !!
If somebody is willing to swallow $30 mil worth of stock it means the company has something to offer... !!
O S ...68 mill (nasd).....todays offering for additional 30 mill plus wrnts...........100 mill plus O S .....0 revenue, and TSC..(crappy science)... expect this to pull back to $1.20 or more......might be worth a flip.....down near a buck......
bottom line : crappy bio..crappy science....wish i didn`t waste 20 minutes on D D ............glta holding this bag!
* * $DFFN Video Chart 02-16-2021 * *
Link to Video - click here to watch the technical chart video
$DFFN stock is screaming for the top after the company announced positive data from its TSC candidate in COVID-19 patients. https://cnafinance.com/dffn-stock-diffusion-flies-on-covid-19-news/
DFFN$ $2 TARGET PRICE TODAY WOOHOOOOOOOOOO
So with this $30M raise, how much cash will they have on hand? Last Q on 9/30 said $22M cash. So they could have close to $50M cash ..is that right?
DFFN$ $5 TARGET PRICE WOOHOOOOOOOOOOOOOOO
* * $DFFN Video Chart 02-12-2021 * *
Link to Video - click here to watch the technical chart video
Wow... some volume today... !! will it get back to the 1.30's+ ??
A long time holder here. Also you need to diversify your portfolio. Buy CTRM also. It's been doing pretty well.
*Diffusion Pharmaceuticals Received Written Notice From Nasdaq Confirming Co Has Regained Compliance
Benzinga
*Diffusion Pharmaceuticals Received Written Notice From Nasdaq Confirming Co Has Regained Compliance
Benzinga
*Diffusion Pharmaceuticals Received Written Notice From Nasdaq Confirming Co Has Regained Compliance
Benzinga
*Diffusion Pharmaceuticals Received Written Notice From Nasdaq Confirming Co Has Regained Compliance
Benzinga
PR will be coming
$DFFN
Remember all, there wont be any PR related to compliance until the NASDAQ sends the company official notice that compliance has been achieved. The company will not have news until that happens.
PR will be coming
$DFFN
Remember all, there wont be any PR related to compliance until the NASDAQ sends the company official notice that compliance has been achieved. The company will not have news until that happens.
I still holding a nice chunk here.hope you doing good my friend.still holding all 3 tickers DFFN TTOO AYTU. Hope you are too.
DO NOT FLIP THIS STOCK!!!!!!!!$DFFN
There is only one reason that they brought Jane Hollingsworth to the Board...her experience with business development. There is only one reason that she would have come to a tiny micro cap...a strong belief that the stock price is going WAY up. That should be all you need to have the confidence to sit patiently and wait.
still holding my self to. got a big position still
Near Term Milestones
Jan 2021 Announce TCOM study design
1Q 2021 Anticipated initiation of TCOM studt
2Q 2021 Initiation of DLCO Study
2Q 2021 Topline data from TCOM Study
3Q2021 Topline data from DLCO Study
2H2021 Initiate confirmatory trial in to-be specified indication
DFFN PowerPoint states
Topline data: Late 1Q 2021 from Covid 303 Study
Near Term Milestones
Jan 2021 Announce TCOM study design
1Q 2021 Anticipated initiation of TCOM studt
2Q 2021 Initiation of DLCO Study
2Q 2021 Topline data from TCOM Study
3Q2021 Topline data from DLCO Study
2H2021 Initiate confirmatory trial in to-be specified indication
Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
Source: GlobeNewswire Inc.
Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows:
Event: H.C. Wainwright BioConnect 2021 Conference
Date: January 11-14, 2021
Registration: https://hcwevents.com/bioconnect/
The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals’ website.
About Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Diffusion’s lead product candidate, trans sodium crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and difficult-to-treat conditions. In addition to TSC, our product candidate DFN-529, a novel PI3K/Akt/mTOR pathway inhibitor, is in early-stage development. We continue to explore alternatives regarding how best to capitalize upon the value of DFN-529 and our associated intellectual property. For more information, please visit us on the web at www.diffusionpharma.com.
8-K Looks like news is coming https://sec.report/Document/0001437749-21-000412/
DFFN needed against Covid
"What's concerning about the South African variant is that they mutate the spike protein where we develop some of our best antibodies," says @ScottGottliebMD. "The worry is if you change that region of the spike protein enough ... the antibodies you're left with aren't as good." pic.twitter.com/oqa2RfF5qm
— Squawk Box (@SquawkCNBC) January 8, 2021
“Zacks report gave this a $2 price target.”
Pop pop pop!!!
BooDog hope you are still holding its going to go much higher
Do not sell at $2 hold for $15 or $20 Big PAY OFF IS coming.
finally it break that$1.00 price. still holding a big chunk here
$2 - It's moving in that direction...
DFFN...8298...in the P/M...Psar flipped to a Bullish Buy Position...Looking for $1 Breakout here...imo...we shall see...
[9:08 AM]
georgie1812/23/2020
DFFN....74...Reversal Candle off the lower band...adding accordingly up or down...$1 Breakout setting up here ...imo...we shall see...
Remember: “Diffusion currently intends to participate in two virtual, biopharmaceutical and biotechnology industry conferences in mid-January 2021 – Biotech Showcase and the H.C. Wainwright 2021 Bioconnect Conference – and to provide its next update regarding its development program for TSC at that time.”
Break and old .80 and $1.00 is a target zone.
DFFN...7846...Psar ready to flip Bullish here...imo..we shall see...:party:
georgie1812/23/2020
DFFN....74...Reversal Candle off the lower band...adding accordingly up or down...$1 Breakout setting up here ...imo...we shall see...:party:
Hold on to your shares. dp not sell for chump change.
DFFN....74...Reversal Candle off the lower band...adding accordingly up or down...$1 Breakout setting up here ...imo...we shall see...
mojo joyo time to load up on dffn before the news. fri was
just a sample of what will happen later.
still own a chunk here.looking good past week or so.need news they are past due on news.
Today wasn’t even news. Zacks already had a $2 PT on it and all information provided was already given in the business update. Wait until actual news hits...
Today wasn’t even news. Zacks already had a $2 PT on it and all information provided was already given in the business update. Wait until actual news hits...
DFFN
The end of the road????? $2 is not the end of the road.
Nobody knows when the road ends. I hope many folks hold
on for the big pay check. just remember. its larger than $2.
$2 is chump change. Hold on to your shares.
This is the beginning of a great event.
$2 is chump change. Hold on to your shares.
This is the beginning of a great event.
Just my opinion, LII's are a joke. Of course Zacks is probably helping the shorts.
Suggest you guys cover. SOON!!
Shares of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) rose by 4.1% from the previous closing price. A Form 4 filing filed with the SEC on Wednesday, November 18 showed that & Secretary Elder William Robert bought 10,000 shares at $0.67 on Monday, Nov 16, and bought 5,000 shares at $0.63 on Tuesday, Nov 17.The transaction moved the executive's stake in Diffusion Pharmaceuticals Inc. to 10,000 shares.
https://finance.yahoo.com/news/insider-buys-diffusion-pharmaceuticals-shares-165536674.html
Zacks report gave this a $2 price target.
SOUNDS GOOD TO ME!!!!!
https://finance.yahoo.com/news/dffn-planning-additional-studies-tsc-122000516.html
Followers
|
62
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3516
|
Created
|
11/15/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |